Related posts
2 Big Technology Stocks That Are BackStocks sink, oil risesU.S markets close down for the week, TSX steadierThis summary was created by AI, based on 3 opinions in the last 12 months.
Overall, the experts seem to have mixed feelings about Docusign's future prospects. While the company is dominant in its industry, there are concerns about increasing competition and the lack of unique software. The new CEO's cost-cutting measures have been effective, but the stock's performance has been stagnant. There is speculation about a potential acquisition by a larger player like MSFT. With lingering post-Covid effects and a crowded market, some experts are cautious about investing in Docusign at this time.
It has maxed out to a large degree on the growth side. It is still dominant in the space and could be an acquisition target.
Dominates this business, but ADBE has entered the space. Stock's gone sideways. Software is not unique, and competition will show up. Perhaps a bigger player like MSFT would buy it and incorporate the technology.
Has a new CEO since last year and he's aggressively cut costs. Last month, they reported one of their best quarters in years, but shares didn't get any traction.
Likes and uses its software, but it's still too close to its post-Covid hangover to buy. There are too many competitors, too.
Docusign is a American stock, trading under the symbol DOCU-Q on the NASDAQ (DOCU). It is usually referred to as NASDAQ:DOCU or DOCU-Q
In the last year, 2 stock analysts published opinions about DOCU-Q. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Docusign.
Docusign was recommended as a Top Pick by on . Read the latest stock experts ratings for Docusign.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
2 stock analysts on Stockchase covered Docusign In the last year. It is a trending stock that is worth watching.
On 2024-08-30, Docusign (DOCU-Q) stock closed at a price of $59.27.
Their Q2 earnings beat. A pandemic darling that then crashed. But now it trades at a fair valuation and strong free cash flow. She bought it last September is up 35%. Trades at 16x PE and has a 8% free cash flow yield. Great managers who underpromise, so they will beat their quarter. Has real secular growth.